Prosecution Insights
Last updated: October 01, 2026
Application No. 19/030,494

LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS

Non-Final OA §103§DP
Filed
Jan 17, 2025
Priority
Oct 25, 2011 — provisional 61/551,366 +6 more
Examiner
YOUNG, MICAH PAUL
Art Unit
Tech Center
Assignee
The University of British Columbia
OA Round
1 (Non-Final)
55%
Grant Probability
Moderate
1-2
OA Rounds
1y 11m
Est. Remaining
85%
With Interview

Examiner Intelligence

Grants 55% of resolved cases
55%
Career Allowance Rate
542 granted / 983 resolved
-4.9% vs TC avg
Strong +30% interview lift
Without
With
+30.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
42 currently pending
Career history
1026
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
56.5%
+16.5% vs TC avg
§102
17.3%
-22.7% vs TC avg
§112
9.5%
-30.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 983 resolved cases

Office Action

§103 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Information Disclosure Statement The information disclosure statement (IDS) submitted on 1/17/25 and 11/06/25 was filed in a timely manner. The submission is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Claim Rejections - 35 USC § 103 The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under pre-AIA 35 U.S.C. 103(a) are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim 1 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Karnik et al (US 2010/0022680 A hereafter Karnik). Karnik discloses a device and system comprising an inlet microchannel for receiving a first solution and providing a first stream, a second inlet for receiving a second solution and providing a second stream and a third microchannel for receiving the first and second stream and mixing them where the third microchannel has a diameter of about 100 microns [abstract, 0022, 0060, 0070]. The mixer can be a micromixer, such as a chaotic advecation micromixer [0060]. The third channel can also comprise herringbone bas-relief structure [Figures]. The channels have a flow rate of about 1 mL/min, and vary depending on the end use [0087]. The system comprises multiple streams and their flow rate is regulated by the source fluid. Adding the stream flows of at least 2 would result in a flow rate of at least 2.0 mL/min [0089]. The third microchannel has a principal flow direction and one or more surfaces having at least one groove having an orientation forms an angle with principal direction [0067]. Regarding the ratio of the first to second or third streams, it is the position that such limitation do not distinguish over the prior art. These limitations could be achieved through routine experimentation that would have been obvious to those of ordinary skill in the art. The general conditions of streams flowing at a rate of 1.0 mL/minute with multiple streams adding to at least 2.0 mL/min are established by the prior art. Where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. See In re Aller, 220 F.2d 454 105 USPQ 233, 235 (CCPA 1955). With these aspects in mind, it would have been obvious to one of ordinary skill in the art to form a system that produces uniform nanoparticles. It would have been obvious to optimize the disclosures of Karnik to adjust the flow rate in order to achieve optimum particles production. One of ordinary skill in the art would have been motivated to optimize these disclosures to produce uniform and stable microparticles. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claim 1 rejected on the ground of nonstatutory double patenting as being unpatentable over claim 11 of U.S. Patent No. 9,943,846. Although the claims at issue are not identical, they are not patentably distinct from each other because both sets of claims are drawn to a system comprising a first, second and third inlet microchannel, a region adapted for mixing the inlet streams and a first and second pump where the ratio of the flow rate to the second flow rate is 2.0-10.0 and a combined flow rate from at least 2 mL/min. The claims differ in that the 846 claim recites the size of the resulting outlet particles, while the instant claim is silent. However, the scopes overlap by providing a system with the same features and the instant claim does not foreclose those limitations. The claims cannot be allowed together. Claim 1 rejected on the ground of nonstatutory double patenting as being unpatentable over claim 11 of U.S. Patent No. 10,843,194. Although the claims at issue are not identical, they are not patentably distinct from each other because both sets of claims are drawn to a system comprising a first, second and third inlet microchannel, a region adapted for mixing the inlet streams and a first and second pump where the ratio of the flow rate to the second flow rate is 2.0-10.0 and a combined flow rate from at least 2 mL/min. The claims differ in that the 846 claim recites the size of the resulting outlet particles, while the instant claim is silent. However, the scopes overlap by providing a system with the same features and the instant claim does not foreclose those limitations. The claims cannot be allowed together. Claim 1 rejected on the ground of nonstatutory double patenting as being unpatentable over claim 15 of U.S. Patent No. 11,648,556. Although the claims at issue are not identical, they are not patentably distinct from each other because both sets of claims are drawn to a system comprising a first, second and third inlet microchannel, a region adapted for mixing the inlet streams and a first and second pump where the ratio of the flow rate to the second flow rate is 2.0-10.0 and a combined flow rate from at least 2 mL/min. The claims differ in that the 846 claim recites the size of the resulting outlet particles, while the instant claim is silent. However, the scopes overlap by providing a system with the same features and the instant claim does not foreclose those limitations. The claims cannot be allowed together. Claim 1 rejected on the ground of nonstatutory double patenting as being unpatentable over claim 15 of U.S. Patent No. 12,233,416. Although the claims at issue are not identical, they are not patentably distinct from each other because both sets of claims are drawn to a system comprising a first, second and third inlet microchannel, a region adapted for mixing the inlet streams and a first and second pump where the ratio of the flow rate to the second flow rate is 2.0-10.0 and a combined flow rate from at least 2 mL/min. The claims differ in that the 846 claim recites the size of the resulting outlet particles, while the instant claim is silent. However, the scopes overlap by providing a system with the same features and the instant claim does not foreclose those limitations. The claims cannot be allowed together. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICAH PAUL YOUNG whose telephone number is (571)272-0608. The examiner can normally be reached Monday through Friday, 9:00 am to 5:30 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Hartley can be reached at 5712720616. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICAH PAUL YOUNG/Primary Examiner, Art Unit 1618
Read full office action

Prosecution Timeline

Jan 17, 2025
Application Filed
Sep 09, 2026
Non-Final Rejection mailed — §103, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746598
BIMETALLIC FLUORESCENT NANOCOMPOSITES FOR CANCER THERANOSTICS
4y 0m to grant Granted Sep 29, 2026
Patent 12734254
PROBE DIRECTED TO ENZYME ALDH1A3 AND USE THEREOF IN THE DIAGNOSIS OF GLIOBLASTOMA
2y 11m to grant Granted Sep 15, 2026
Patent 12714677
DUAL CHAMBER SYRINGE FOR ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL
1y 6m to grant Granted Aug 25, 2026
Patent 12708605
METHOD OF ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL WITH A DUAL CHAMBER SYRINGE
1y 5m to grant Granted Aug 18, 2026
Patent 12702647
ENTERIC BISACODYL SOFTGEL CAPSULE
1y 11m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
55%
Grant Probability
85%
With Interview (+30.0%)
3y 7m (~1y 11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 983 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month